Injectable cross-linked collagen implant material
AssigneeCollagen Corporation
InventorsThomas L. Smestad, John McPherson, Donald G. Wallace
Life of this patent
Estimating the term…
Loading patent…
AssigneeCollagen Corporation
InventorsThomas L. Smestad, John McPherson, Donald G. Wallace
Estimating the term…
Cross-linked atelopeptide collagen that is substantially free of residual cross-linking agent is prepared by: reconstituting atelopeptide collagen from solution by neutralizing the solution at a reduced temperature and a hypotonic ionic strength; cross-linking the reconstituted fibers in an aqueous medium at a concentration of 0.1 to 10 mg/ml with glutaraldehyde under conditions that produce cross-linked collagen that when in suspension in physiological saline at a concentration of 35 mg/ml exhibits a shear viscosity whose log varies linearly with the log of the shear rate and is approximated by the formula log .eta..ltoreq.-0.96 log .gamma.+2.3 where .gamma. is the shear rate in sec.sup.-1, log .gamma. is in the range of -6 to +2 and .eta. is the viscosity of the suspension in Pascal-sec; optionally quenching the cross-linking reaction with an amino acid; and separating the cross-linked atelopeptide collagen from the reaction mixture. This collagen is dispersed in an isotonic aqueous medium for use in soft tissue dermal augmentation and is injectable and forms implants that have excellent persistence.
A novel cross-linked atelopeptide collagen for use as an injectable aqueous suspension for augmenting soft tissue that:
A process for preparing cross-linked atelopeptide collagen for use as an injectable aqueous suspension for augmenting soft tissue comprising:
Dependencies are inferred from the claim text.